Cargando…
Anaphylaxis after Idarucizumab Infusion
Autores principales: | Nam, Ki-Woong, Choo, Ilyeon, Chang, Jun Young, Jung, Seunguk, Kim, Beom-Joon, Han, Moon-Ku, Bae, Hee-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653635/ https://www.ncbi.nlm.nih.gov/pubmed/28831791 http://dx.doi.org/10.3988/jcn.2017.13.4.432 |
Ejemplares similares
-
Idarucizumab: A novel antidote for reversal of dabigatran
por: Rehman, Abdul, et al.
Publicado: (2016) -
Early Statins after Intravenous or Endovascular Recanalization Is Beneficial Regardless of Timing, Intensity, and Stroke Mechanism
por: Jeong, Han-Gil, et al.
Publicado: (2017) -
Levodropropizine-Induced Anaphylaxis: Case Series and Literature Review
por: Song, Jae-Won, et al.
Publicado: (2017) -
Authors’ Reply to Kamel et al.: “Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study”
por: Glund, Stephan, et al.
Publicado: (2016) -
Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
por: Litwinowicz, Radoslaw, et al.
Publicado: (2017)